Melatonin and the Developing Sleep System
Neurology
The latest headlines across every section, pulled from official and open-access sources.
Neurology
This secondary analysis of randomized clinical trial investigates whether adopting a vegan diet is associated with reduced dietary energy density.
This cohort study evaluates postsurgical outcomes among Medicare beneficiaries with rural vs nonrural residence undergoing common surgical procedures.
This cross-sectional study examines whether outpatient melatonin use in children is associated with differences in objectively measured sleep architecture using polysomnography.
This systematic review and meta-analysis evaluates the functional and safety outcomes associated with intravenous thrombolysis administered 4.5 hours or more after symptom onset in patients with acute ischemic stroke.
This randomized clinical trial evaluates the effectiveness of a role-playing–based intensive training program for physicians compared with regular physician training in improving glycemic control among patients with type 2 diabetes.
This systematic review and meta-analysis assesses changes in mental health symptoms from before to during the COVID-19 pandemic by sex and gender.
This qualitative study investigates the experiences of out-of-state individuals who travel to central and southern Illinois to receive abortion care.
UnityPoint Health’s chief medical officer, Gregory Johnson, shared several ways the system is using AI to lift administrative burden off clinicians and get them back to patient care — including ambient scribing, real-time capacity tracking and AI-powered chart review. The post 6 Ways UnityPoint Health Is Trying to Make Clinicians’ Jobs Easier appeared first on MedCity News .
Curative Insurance Company partnered with Wondr Health to expand weight management support for its members. The post Curative, Wondr Health Team Up for Weight and Metabolic Health Support appeared first on MedCity News .
FOR IMMEDIATE RELEASE – August 5, 2026 – Austin, Texas, Victory Medical Center Pharmacy is voluntarily recalling certain lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials to the patient level. The product is being recalled because pharmacy testing identified elevated bacterial endotoxin leve
£343 million plan will open 159 NHS mental health centres in England, giving people earlier local support and specialist crisis care outside A&E.
Medtronic’s George Murgatroyd says an advanced computing platform that works with the company’s Hugo robot will power AI algorithms that can assist surgeons as they operate.
In patients with invasively confirmed angina with no obstructive coronary artery disease (ANOCA), adding a structured multidomain lifestyle intervention to medical therapy tailored to each patient’s ANOCA endotype led to clinically meaningful improvements in patient-reported health status, according to results from the prospective SAMCRO trial published July 27 in JACC: Cardiovascular Interventions.
Women undergoing intervention for primary mitral regurgitation (PMR) are older, more symptomatic and have worse long-term outcomes than men, according to a systematic review and meta-analysis published July 21 in JACC: Cardiovascular Imaging.
The Centers for Medicare and Medicaid Services (CMS) released the 2027 Inpatient Prospective Payment System (IPPS) final rule on July 31. The rule includes a net increase to inpatient hospital payment of 2.3%, reflecting a 3.2% increase in the hospital market basket reduced 0.9% by the productivity adjustment.
NCQA is ready to roll out the person-centered outcome (PCO) measures in HEDIS® MY 2027 for Dual-Eligible Special Needs Plans (D-SNP) and Chronic Condition Special Needs Plans (C-SNP). Unlike traditional care process measures, the PCO measures incorporate the person’s voice into the care plan and quality measurement. “We have an enormous opportunity to continue to […] The post Person-Centered Outcome Measures Are Approved for HEDIS MY 2027 appeared first on NCQA .
Health and Social Care Secretary announces faster access to care and support for motor neurone disease patients during a visit to the Rob Burrow Centre.
The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.
Attovia Therapeutics’ biologic medicines could offer advantages over currently available immune disorder drugs, such as Sanofi’s blockbuster medicine Dupixent. The IPO comes as Attovia looks to expand clinical development of its pipeline in 2027. The post Attovia’s Upsized IPO Brings In $289M to Fund New Kind of Biologic for Immune Disorders appeared first on MedCity News .
Two and a half years into his tenure as Emergent BioSolutions CEO, Joseph Papa is executing another round of restructuring to align the business with “current business realities.”
The American Diabetes Association Applauds Hawai’i’s Enactment of SB 3045, Expanding Access to Continuous Glucose Monitors mcarmody Wed, 08/05/2026 - 17:47 Advocacy News The American Diabetes Association Applauds Hawai’i’s Enactment of SB 3045, Expanding Access to Continuous Glucose Monitors HONOLULU, Hawaii August 5, 2026 The American Diabetes Association ® (ADA) applauds Hawaii Governor Josh Green for signing SB 3045 into law, a significant step toward expanding access to continuous glucose monitors (CGMs) for people living with diabetes across Hawaiʻi. The new law requires health…
Decisions made by MHRA on adverts reported to have breached the legislation on advertising medicines.
FOR IMMEDIATE RELEASE – 8/4/2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is voluntarily recalling one lot of Morphine Sulfate Injection USP, Simplist® 2 mg/1 mL due to a label mix-up. The MicroVault labeled as Morphine 2 mg/1 mL, may contain a Prefilled Syri